RESUMEN
We demonstrate herein the variation in viscoelastic properties of supramolecular hydrogels (SMGs) composed of two amphiphiles, N-Palmitoyl-Gly-His (PalGH) and sodium palmitate (PalNa). PalGH molecules in water form lamellar-like assemblies, which stack into sheet-shaped aggregates, resulting in the evolution of three-dimensional network structures. Once PalNa is added to PalGH, the alkyl groups of PalNa incorporate themselves into the hydrophobic cores of PalGH lamellar-like assemblies, resulting in a change in the assembly from lamellar-like to fibrous micelle-like. Consequently, sheet-shaped aggregates turn into flexible fibrils, which form bundles, resulting in network structures. Mixed hydrogel network structures differ in morphology from those in homogenous PalGH and PalNa hydrogels. Changes in the network structure eventually alter the bulk viscoelastic properties of hydrogels. These results demonstrate that the viscoelastic properties of supramolecular hydrogels can be tuned by controlling the aggregation states.
RESUMEN
OBJECTIVE: The signaling by thrombopoietin (TPO) via its receptor, c-MPL, plays a crucial role in the maintenance of hematopoietic stem cells (HSCs). Small-molecule c-MPL agonists have recently been shown to be beneficial in the treatment of thrombocytopenia. However, their effects on HSCs have not yet been explored. In this study, we evaluated the effects of NR-101, a novel small-molecule c-MPL agonist, on the ex vivo expansion of human cord blood (hCB) HSCs. MATERIALS AND METHODS: hCB CD34(+) or CD34(+)CD38(-) hematopoietic stem and progenitor cells were cultured for 7 days in the presence of thrombopoietin (TPO) or NR-101, and then subjected to flow cytometric analyses, colony-forming cell assays, and severe combined immunodeficiency-repopulating cell assays. RESULTS: During a 7-day culture of CD34(+) or CD34(+)CD38(-) hematopoietic stem and progenitor cells, NR-101 efficiently increased their numbers, with a greater than twofold increase compared to TPO, although its effect on megakaryocytopoiesis was comparable to that of TPO. Correspondingly, severe combined immunodeficiency-repopulating cells were increased 2.9-fold during a 7-day culture with NR-101 compared to freshly isolated CD34(+) cells, and 2.3-fold compared to that with TPO. Of note, NR-101 persistently activated signal transducer and activator of transcription (STAT) 5 but not signal transducer and activator of transcription 3. Furthermore, NR-101 induced a long-term accumulation of hypoxia-inducible factor-1alpha protein and enhanced activation of its downstream target genes. CONCLUSION: This is the first time that a small-molecule c-MPL agonist has been demonstrated to promote net expansion of HSCs. NR-101 is more efficient in ex vivo expansion of HSCs than TPO. NR-101 could be a useful tool for the therapeutic manipulation of human HSCs.